LAURUS LABS Financial Statement Analysis
|
||
The Revenues of LAURUS LABS have increased by 2.54% YoY .
The Earnings Per Share (EPS) of LAURUS LABS has decreased by -5.45 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
LAURUS LABS Last 5 Annual Financial Results
[BOM: 540222|NSE : LAURUSLABS]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹4,936 Cr | ₹4,814 Cr | ₹2,832 Cr | ₹22,919 Cr | ₹2,056 Cr |
Expenses | ₹3,513 Cr | ₹3,263 Cr | ₹2,267 Cr | ₹19,359 Cr | ₹1,643 Cr |
Operating Profit (Excl OI) | ₹1,422 Cr | ₹1,551 Cr | ₹565 Cr | ₹3,560 Cr | ₹413 Cr |
Other Income | ₹15 Cr | ₹24 Cr | ₹5.92 Cr | ₹162 Cr | ₹29 Cr |
Interest | ₹102 Cr | ₹68 Cr | ₹90 Cr | ₹882 Cr | ₹80 Cr |
Depreciation | ₹251 Cr | ₹205 Cr | ₹187 Cr | ₹1,642 Cr | ₹125 Cr |
Profit Before Tax | ₹1,084 Cr | ₹1,301 Cr | ₹294 Cr | ₹1,198 Cr | ₹237 Cr |
Profit After Tax | ₹832 Cr | ₹984 Cr | ₹255 Cr | ₹938 Cr | ₹168 Cr |
Consolidated Net Profit | ₹828 Cr | ₹984 Cr | ₹255 Cr | ₹938 Cr | ₹168 Cr |
Earnings Per Share (Rs) | ₹14.56 | ₹15.40 | ₹18.33 | ₹23.88 | ₹8.81 |
PAT Margin (%) | 13.19 | 16.87 | 20.44 | 9.01 | 4.09 |
ROE(%) | 21.63 | 28.05 | 45.15 | 15.39 | 6.19 |
ROCE(%) | 22.97 | 25.97 | 39.82 | 14.14 | 8.22 |
Total Debt/Equity(x) | 0.49 | 0.52 | 0.56 | 0.60 | 0.67 |
Key Financials |
||
Market Cap | : | ₹ 23,899.3 Cr |
Revenue (TTM) | : | ₹ 5,040.8 Cr |
Net Profit(TTM) | : | ₹ 168.2 Cr |
EPS (TTM) | : | ₹ 3.1 |
P/E (TTM) | : | 142.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
LAURUS LABS | 2.4% | 11.6% | 47.9% |
SUN PHARMACEUTICAL INDUSTRIES | 2.6% | -4.7% | 54.7% |
CIPLA | 4.4% | -4.4% | 54.7% |
DR REDDYS LABORATORIES | 5.7% | 2.7% | 29.3% |
ZYDUS LIFESCIENCES | 0.4% | -5.4% | 82.7% |
DIVIS LABORATORIES | 5.8% | 17.7% | 24.8% |
MANKIND PHARMA | -0.4% | 6% | NA |
TORRENT PHARMACEUTICALS | 2% | 4.6% | 63.9% |
LUPIN | 3.6% | 1.6% | 129.3% |
LAURUS LABS Revenues
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | 2.54 % |
5 Yr CAGR | 24.47 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹4,936 Cr | 2.54 | |
Mar2022 | ₹4,814 Cr | 69.99 | |
Mar2021 | ₹2,832 Cr | -87.64 | |
Mar2020 | ₹22,919 Cr | 1,014.65 | |
Mar2019 | ₹2,056 Cr | - |
LAURUS LABS Operating Profit
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | -8.27 % |
5 Yr CAGR | 36.20 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹1,422 Cr | -8.27 | |
Mar2022 | ₹1,551 Cr | 174.68 | |
Mar2021 | ₹565 Cr | -84.14 | |
Mar2020 | ₹3,560 Cr | 761.27 | |
Mar2019 | ₹413 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -10.55 % |
5 Yr CAGR | 9.43 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 28.82% | -10.55 | |
Mar2022 | 32.22% | 61.58 | |
Mar2021 | 19.94% | 28.40 | |
Mar2020 | 15.53% | -22.74 | |
Mar2019 | 20.1% | - |
LAURUS LABS Profit After Tax
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | -15.87 % |
5 Yr CAGR | 49.06 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹828 Cr | -15.87 | |
Mar2022 | ₹984 Cr | 285.31 | |
Mar2021 | ₹255 Cr | -72.78 | |
Mar2020 | ₹938 Cr | 459.42 | |
Mar2019 | ₹168 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -21.81 % |
5 Yr CAGR | 34.01 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 13.19 % | -21.81 | |
Mar2022 | 16.87 % | -17.47 | |
Mar2021 | 20.44 % | 126.86 | |
Mar2020 | 9.01 % | 120.29 | |
Mar2019 | 4.09 % | - |
LAURUS LABS Earnings Per Share (EPS)
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | -5.45 % |
5 Yr CAGR | 13.38 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹15 | -5.45 | |
Mar2022 | ₹15 | -15.98 | |
Mar2021 | ₹18 | -23.24 | |
Mar2020 | ₹24 | 171.06 | |
Mar2019 | ₹8.81 | - |
LAURUS LABS Return on Capital Employed (ROCE)
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | -11.55 % |
5 Yr CAGR | 29.29 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 22.97% | -11.55 | |
Mar2022 | 25.97% | -34.78 | |
Mar2021 | 39.82% | 181.61 | |
Mar2020 | 14.14% | 72.02 | |
Mar2019 | 8.22% | - |
LAURUS LABS Share Price vs Sensex
Current Share Price | : | ₹443.4 |
Current MarketCap | : | ₹ 23,899.3 Cr |
Updated EOD on | : | Apr 29,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 2.4% |
11.6% |
47.9% |
SENSEX | 1.4% |
2.5% |
24.3% |
LAURUS LABS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MID CAP | 3.8% | 8% | 67.9% |
S&P BSE 150 MIDCAP | 3.4% | 7.9% | 60% |
S&P BSE 400 MIDSMALLCAP | 3.3% | 8.8% | 61.9% |
S&P BSE MIDSMALLCAP | 3.3% | 9.3% | 67.3% |
S&P BSE HEALTHCARE | 2.2% | 3.1% | 56.5% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY FREE MIDCAP 100 | 3.5% | 7.4% | 62.9% |
NIFTY MIDCAP150 | 3.4% | 7.7% | 60.6% |
NIFTY MID SMALL400 | 3.3% | 9.1% | 64.6% |
NIFTY HEALTHCARE | 2.5% | 1.6% | 52.8% |
NIFTY LARGE MIDCAP 250 | 2.5% | 5.6% | 46.7% |
You may also like the below Video Courses
FAQ about LAURUS LABS Financials
How the annual revenues of LAURUS LABS have changed ?
The Revenues of LAURUS LABS have increased by 2.54% YoY .
How the Earnings per Share (EPS) of LAURUS LABS have changed?
The Earnings Per Share (EPS) of LAURUS LABS has decreased by -5.45 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs